May 25, 2022 06:30AM
May 10, 2022 06:30AM
Apr 13, 2022 06:30AM
Mar 31, 2022 06:30AM
Mar 21, 2022 06:30AM
Mar 1, 2022 06:30AM
Feb 16, 2022 06:30AM Cerevel Therapeutics to Report Fourth Quarter 2021 Financial Results and Pipeline Update on Tuesday, March 1, 2022
Feb 15, 2022 06:30AM
Feb 15, 2022 06:30AM
Jan 10, 2022 06:30AM
Jan 3, 2022 07:00AM
Dec 16, 2021 07:00AM
Nov 10, 2021 06:30AM
Nov 1, 2021 06:30AM Cerevel Therapeutics to Participate at Upcoming Virtual Investor Conferences
Oct 20, 2021 06:30AM
Oct 7, 2021 07:00AM
Sep 21, 2021 05:01PM
Sep 21, 2021 05:00PM
Sep 10, 2021 07:00AM
Sep 1, 2021 07:00AM
Aug 11, 2021 06:30AM Cerevel Therapeutics Reports Second Quarter 2021 Financial Results and Business Updates
Jul 30, 2021 07:00AM
Jul 22, 2021 07:00AM
Jul 2, 2021 05:00AM
Jul 1, 2021 09:50PM
Jun 29, 2021 04:25PM
Jun 29, 2021 04:24PM
Jun 29, 2021 06:31AM Ceres (CERE) Announces Positive Topline Results for CVL-231 in Phase 1b Clinical Trial in Patients with Schizophrenia
Jun 29, 2021 06:30AM
Jun 15, 2021 07:05AM
Jun 15, 2021 07:00AM
May 27, 2021 07:00AM
May 17, 2021 06:30AM
Apr 29, 2021 07:00AM
Apr 13, 2021 06:33AM Ceres (CERE) Announces Strategic $125 Million Non-Dilutive Financing Transaction for Tavapadon
Apr 13, 2021 06:30AM
Mar 24, 2021 06:30AM
Mar 22, 2021 07:00AM
Feb 24, 2021 07:00AM
Feb 23, 2021 07:00AM
Jan 28, 2021 07:00AM
Dec 14, 2020 07:00AM Cerevel Therapeutics to Host Inaugural Virtual R&D Event
Dec 4, 2020 07:00AM
Nov 23, 2020 07:00AM
Nov 16, 2020 06:30AM

322,897 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All